Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262301
Status:
COMPLETED
Last Update Posted:
2012-10-02
First Post:
2005-12-01
Brief Title:
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Sponsor:
Pharming Technologies BV
Organization:
Pharming Technologies BV
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Genetic Disorders |
| Hereditary Angioedema |
| Angioneurotic Edema |
Keywords: